A 48-year-old man sits in my consultation room with a folder of labs from three different providers and one specific question: "Should I do pellets or injections?" He has been told both. He has read both. He has friends on both. What he actually needs from me is not an opinion on which is better in the abstract — that question has no good answer in the abstract — but a recommendation for his physiology, his lifestyle, his goals, and his tolerance for the trade-offs that each delivery method actually carries.
This is the conversation I have several times a week. The choice between pellets and injections is real, the trade-offs are real, and the right answer depends on the patient in front of me. I want to walk through how I actually compare them in clinical practice — for both men and women — so that when you sit down for a hormone consultation, the conversation can move past marketing and into your specific picture.
What each delivery method actually is
Subcutaneous testosterone pellets — the Biote method is the one I use — are small, compressed cylinders of bioidentical testosterone (and for women, sometimes estradiol) that are inserted under the skin of the upper buttock through a small incision after local anesthesia. The procedure takes about ten minutes. The pellets dissolve gradually, releasing hormone in response to cardiac output — when you exercise and your circulation increases, slightly more hormone releases; when you are at rest, less. Pellets last roughly three to five months in men and three to four months in women, depending on metabolism, body composition, and activity level.
Intramuscular or subcutaneous testosterone injections — testosterone cypionate is the workhorse — deliver a measured dose into muscle (or subcutaneous tissue, which has become more common in recent practice) on a defined schedule, usually weekly or twice weekly. The patient typically self-administers at home after training, though some prefer to come in for the injection. The dose is fully adjustable visit-to-visit based on labs and symptom response.
Topical testosterone — creams or gels — exists as a third option, applied daily. I use it less commonly than pellets or injections for reasons I will get to.
These are different drug delivery profiles producing different serum hormone curves. That is the heart of the comparison.
The mechanism that makes the difference — pharmacokinetics
Two patients on different delivery systems with the same total weekly dose can have very different clinical experiences because the shape of the curve matters as much as the area under it.
Injection pharmacokinetics. A standard cypionate injection produces a serum testosterone peak 24 to 72 hours after the injection and a trough at the end of the dosing interval. With weekly injections, the peak-to-trough swing is meaningful — patients often describe feeling best in the first half of the week and noticeably less well in the day or two before the next injection. Twice-weekly dosing flattens the curve substantially and is what I prefer for most male patients on injections. Estradiol conversion via aromatase tracks with the testosterone peak, which is why some patients on once-weekly cypionate experience estrogen-related symptoms (water retention, mood lability, nipple sensitivity) clustered around the peak.
Pellet pharmacokinetics. Pellets produce a relatively flat serum curve over their dosing interval — there is an early small rise as the pellets begin to dissolve, a stable plateau through the middle months, and a gradual decline as they exhaust. The activity-responsive release means the curve adjusts somewhat to demand. Patients who do well on pellets typically describe a smooth, sustained sense of well-being through the cycle without the peak-and-trough pattern that injections produce.
Topical pharmacokinetics. Creams produce a daily peak at application and a rise-and-fall through 24 hours. Adherence is the dominant variable — missed days produce drops. Transfer to spouses, children, and pets is a real concern that I discuss explicitly when this option is on the table.
The right delivery method for an individual patient is the one whose pharmacokinetic profile fits their physiology, their schedule, and their preferences best. There is no abstract winner.
What I look for in the workup
When I evaluate someone for testosterone optimization, the workup is the same regardless of which delivery method we eventually choose. Without comprehensive lab work, any conversation about pellets versus injections is informed guessing.
The panel I order includes total testosterone, free testosterone (calculated from total T and SHBG using the Vermeulen equation, or measured directly), SHBG, estradiol (sensitive assay — the standard assay is unreliable in men), LH and FSH (to distinguish primary from secondary hypogonadism), DHEA-S, a full thyroid panel (TSH, free T3, free T4, reverse T3, thyroid antibodies), fasting insulin and HbA1c, a comprehensive metabolic panel, lipids, hematocrit and hemoglobin (because erythrocytosis is the most common testosterone side effect), PSA in men over 40, and inflammatory markers when the history indicates.
For women, the panel includes the same sex hormone markers plus progesterone timed to the cycle when relevant. Testosterone in women is not optional in midlife — it is the primary driver of libido and contributes meaningfully to energy, mood, and lean mass — but the dose is a fraction of the male dose and the monitoring is more nuanced.
The first visit is the workup. The second visit, the lab review, is where the actual treatment plan gets built — and where the pellet-versus-injection conversation actually happens, with data on the table.
How I think about which delivery method fits which patient
This is the part that does not get said clearly enough. Some patient profiles match pellets better; some match injections better. I will be specific.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Pellets tend to fit best: patients who do not want to manage a weekly injection schedule, patients who travel frequently and find injection logistics inconvenient, patients who have struggled with the peak-and-trough pattern of injections in the past, patients whose schedule is unpredictable enough that adherence to weekly self-injection is unrealistic, and women in particular who need a low, steady testosterone dose that is difficult to titrate accurately with weekly injections at the female dosing range. The active-duty and recently-separated military patients I see at the Warner Robins clinic frequently choose pellets for the same reasons — operational tempo can disrupt any regular schedule.
Injections tend to fit best: patients who want maximum dose flexibility (the dose can be adjusted visit-to-visit, while pellet dose is locked in for the cycle), patients with elevated SHBG who need higher peak levels to drive adequate free testosterone, patients who want to titrate carefully through small dose changes, patients who tolerate self-injection comfortably, and patients whose initial pellet trial did not produce the result we wanted at the calibrated dose.
The wrong fit is real. A patient who chooses pellets because the marketing was compelling but who actually needed the dose flexibility of injections will be undertreated for the duration of the cycle and unhappy. A patient who chooses injections because they sound more "clinical" but who consistently misses doses because of an unpredictable schedule will be undertreated by adherence. The match matters more than the abstract preference.
The trade-offs I make sure patients understand
Reversibility. Injections are immediately adjustable. Pellets are committed for the duration of the cycle — if the dose turns out to be wrong, the option is to wait it out, supplement with additional injections in the interim (which I do occasionally), or in rare cases remove the pellets surgically. The first pellet cycle is therefore conservatively dosed and adjusted upward at the next insertion if labs and symptoms support it.
Estradiol management. Injection peaks drive aromatization more sharply than pellets do. Patients on injections sometimes need an aromatase inhibitor (anastrozole) at low doses to manage estradiol; patients on pellets less commonly need this. I do not use aromatase inhibitors prophylactically — I use them only when labs and symptoms warrant.
Hematocrit. Both delivery methods raise hematocrit — testosterone stimulates erythropoiesis. The peaks of injection therapy can drive hematocrit elevation more aggressively than the flat pellet curve in some patients. We monitor hematocrit at every reassessment regardless of method, and patients with hematocrit trending above 52 percent need either dose reduction or therapeutic phlebotomy.
Procedure burden. Pellet insertions happen every three to five months in office. Injections happen weekly or twice-weekly at home. Some patients prefer the in-office cadence; some prefer the autonomy of home self-administration. Neither preference is wrong.
Cost structure. Pellets are billed per insertion cycle. Injections are billed per dose dispensed plus monitoring. Total annual cost is comparable in most cases but the cash-flow pattern differs.
How treatment actually proceeds, regardless of method
Once we have selected a delivery method, the treatment pattern is the same: conservative starting dose, follow-up labs at six to eight weeks, dose adjustment based on the labs and your symptom report, reassessment at three months, then ongoing reassessment at six-month intervals.
I do not front-load dose. The patient who feels noticeable improvement at a moderate dose and full optimization at the calibrated dose is doing better than the patient who was overdosed at the start and has to deal with symptoms — water retention, irritability, acne, hematocrit elevation — from a level that was higher than necessary. Conservative titration is what produces a stable, durable result.
For Biote pellet therapy specifically, the first cycle is the data point that informs the second cycle. Trough labs drawn at the end of the first cycle tell me how the patient metabolized the dose, which informs the pellet count for the second insertion. By the second or third cycle, the dose is usually well calibrated.
For injections, the same logic applies on a faster timescale. Six-week labs after starting cypionate at a conservative dose tell us where the steady-state level is sitting and what adjustment is appropriate.
What I look for at follow-up
When I evaluate a patient at the three-month reassessment, I am looking at four things together: the labs (total T, free T, SHBG, estradiol, hematocrit, and any markers that were borderline at baseline), the symptom inventory (energy, sleep, libido, mood, cognitive function, body composition), the side effect profile if any, and the patient's subjective sense of whether the protocol is working. All four matter. A patient with optimal labs who feels no different is a patient I need to look harder at — usually thyroid, sleep, or stress is the limiting factor, not the testosterone dose.
For women on testosterone — which is part of hormone optimization for many of the perimenopausal and menopausal patients I see — the same framework applies at female dosing. The most common pattern I see in women after a few months on testosterone is "I have my libido back, I am sleeping through the night, my workouts are productive again, and I do not feel like I am dragging through every afternoon." That pattern is what we are aiming for, and it is achievable with either delivery method when the dose and the monitoring are right.
For men on testosterone — men's testosterone replacement is one of the highest-volume programs at both clinics — the pattern is similar at male dosing: returning energy, returning libido, returning lean mass response to training, returning cognitive sharpness, improving sleep, and improving the overall sense that the body is working with you instead of against you.
A clear next step
If you have been weighing pellets versus injections, the most useful step is not to keep researching. It is to bring whatever lab work and history you have to a real consultation so the choice can be made on data instead of marketing. Bring any prior hormone panels, prior testosterone treatment history (what dose, what method, for how long, with what result), current medications and supplements, and your top three goals for treatment.
Book a hormone consultation at the Columbus location or Warner Robins location through book a consultation, or take the hormone health assessment first if you want to organize your symptom picture before you walk in. At the consultation we will run the workup, review the labs together, and choose the delivery method that fits your physiology and your life — not the one that is most marketed.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.